Detalhe da pesquisa
1.
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy.
Horm Metab Res
; 50(12): 887-893, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096720
2.
Selenium in Graves Hyperthyroidism and Orbitopathy.
Ophthalmic Plast Reconstr Surg
; 34(4S Suppl 1): S105-S110, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933354
3.
VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY.
Endocr Pract
; 22(10): 1177-1186, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27732097
4.
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial.
Lancet Diabetes Endocrinol
; 9(11): 733-742, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592164
5.
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis.
Eur Thyroid J
; 10(3): 237-247, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34178710
6.
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study.
Thyroid
; 28(3): 386-394, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29336220
7.
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
Lancet Diabetes Endocrinol
; 6(4): 287-298, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396246
8.
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question.
Eur Thyroid J
; 6(5): 263-270, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29071239
9.
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.
Thyroid
; 27(2): 271-278, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27824294
10.
Natural history of graves' orbitopathy after treatment.
Endocrine
; 57(2): 226-233, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27709471
11.
Dissecting the Genetic Susceptibility to Graves' Disease in a Cohort of Patients of Italian Origin.
Front Endocrinol (Lausanne)
; 7: 21, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27014188
12.
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.
Thyroid
; 25(7): 846-50, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26090805
13.
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center.
Thyroid
; 25(3): 347-51, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584927
14.
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.
Eur J Endocrinol
; 172(3): 269-76, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25661744
15.
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.
Br J Ophthalmol
; 99(11): 1531-5, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953846
16.
Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.
Thyroid
; 24(1): 60-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23980907
17.
A swollen, red scar.
Lancet
; 370(9585): 456, 2007 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-17679023
18.
Thyroid volume and severity of Graves' orbitopathy.
Thyroid
; 23(1): 97-102, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23088654
19.
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts.
Thyroid
; 23(1): 92-6, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23030053
20.
Oxidative stress in graves' disease.
Eur Thyroid J
; 1(2): 80-7, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24783001